Silverwood Partners
  • About Us
    • Overview
    • Why Silverwood?
    • Careers
    • Our Location
    • Connect With Us
  • Insights & Analysis
    • Newsletters
    • Intelligence Briefs
    • Events
    • Connect With Us
  • Team
    • All Team
    • Technology
    • Consumer
    • Healthcare
  • Industry Experience
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
  • Services
    • Mergers & Acquisitions
    • Private Placements
    • Connect With Us
  • Transactions
    • All Transactions
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
Select Page
Healthcare Private Placement and M&A Transactions Review Week Ending April 3 2022

Healthcare Private Placement and M&A Transactions Review Week Ending April 3 2022

by Jonathan Hodson-Walker | Apr 4, 2022 | Healthcare

Strategy | Financing Highlight Private Placement / Financing Transactions Aviceda Therapeutics: The company raised $64 million of venture funding from undisclosed investors on March 28, 2022. The company is an operator of a biotech business intended to develop...
Consumer Private Placement and M&A Transactions Review Week Ending April 3 2022

Consumer Private Placement and M&A Transactions Review Week Ending April 3 2022

by Jonathan Hodson-Walker | Apr 4, 2022 | Consumer

Strategy | Financing Highlight Private Placement / Financing Transactions MycoTechnology: The company raised $85 million of Series E venture funding in a deal led by Oman Investment Authority on March 30, 2022, putting the company’s pre-money valuation at $460...
Consumer Private Placement and M&A Transactions Review Week Ending March 27 2022

Consumer Private Placement and M&A Transactions Review Week Ending March 27 2022

by Jonathan Hodson-Walker | Mar 29, 2022 | Consumer

Strategy | Financing Highlight Private Placement / Financing Transactions Ashland Hard Seltzer: The company raised $33.1 million of venture funding from undisclosed investors on March 22, 2022. The company is a producer of hard seltzer beverages that contain no sugar,...
Healthcare Private Placement and M&A Transactions Review Week Ending March 27 2022

Healthcare Private Placement and M&A Transactions Review Week Ending March 27 2022

by Jonathan Hodson-Walker | Mar 29, 2022 | Healthcare

Strategy | Financing Highlight Private Placement / Financing Transactions Osso VR: The company raised $66 million of Series C venture funding in a deal led by Oak HC/FT on March 24, 2022, putting the company’s pre-money valuation at $158 million. Kaiser...
Technology Private Placement and M&A Transactions Review Week Ending March 27 2022

Technology Private Placement and M&A Transactions Review Week Ending March 27 2022

by Jonathan Hodson-Walker | Mar 29, 2022 | Technology

  Strategy | Financing Highlight Private Placement / Financing Transactions Tarana: The company raised $170 million through a combination of debt and Series 6 venture funding in a deal Co-led by Khosla Ventures, Prime Movers Lab, and Axon Capital on March 23,...
« Older Entries
Next Entries »

Search

Recent Posts

  • Technology Private Placement and M&A Transactions Review Week Ending October 26, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending October 26, 2025
  • Healthcare Private Placement and M&A Transactions Review Week Ending October 26, 2025
  • Technology Private Placement and M&A Transactions Review Week Ending October 19, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending October 19, 2025

Categories

Archives